Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Review Article
Authors: Hao, Jing | Guo, Yanping; * | Guo, Keke | Yang, Qingcheng
Affiliations: Department of Neurology, Anyang People’s Hospital, Xinxiang Medical University, Anyang, P.R. China
Correspondence: [*] Correspondence to: Yanping Guo, Department of Neurology, Anyang People’s Hospital, Xinxiang Medical University, Anyang 455000, P.R. China. Tel.: +86 372 2077817; E-mail: [email protected].
Abstract: Alzheimer’s disease (AD) is a neurodegenerative disease of unknown pathological origin. The clinical diagnosis of AD is time-consuming and needs to a combination of clinical evaluation, psychological testing, and imaging assessments. Biomarkers may be good indicators for the clinical diagnosis of AD; hence, it is important to identify suitable biomarkers for the diagnosis and treatment of AD. Peripheral inflammatory biomarkers have been the focus of research in recent years. This review summarizes the role of inflammatory biomarkers in the disease course of AD.
Keywords: Alzheimer’s disease, biomarkers, inflammatory, neurodegeneration
DOI: 10.3233/JAD-215422
Journal: Journal of Alzheimer's Disease, vol. 88, no. 2, pp. 389-398, 2022
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]